Studies on the effect of antifolics in mouse leukemia.
D000367:Age Factors; D000630:Aminopterin / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005558:Arylformamidase / Q000378:metabolism; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D003609:Dactinomycin / Q000627:therapeutic use; D004351:Drug Resistance; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008099:Liver / Q000378:metabolism; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D010088:Oxidoreductases / Q000378:metabolism; D013154:Spleen / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D003609:Dactinomycin; D014750:Vincristine; D010088:Oxidoreductases; D013762:Tetrahydrofolate Dehydrogenase; D005558:Arylformamidase; D000630:Aminopterin; D008727:Methotrexate